This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Shilpa Medicare Limited, Shilpa Pharma Lifesciences Limited. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2024
Title: Rafiuddin Dr: Innovator in Pharmaceutical Processes
Introduction
Rafiuddin Dr is a notable inventor based in Raichur, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important medicinal compounds. With a total of 5 patents to his name, Rafiuddin has established himself as a key figure in pharmaceutical innovation.
Latest Patents
Rafiuddin's latest patents include a process for the preparation of crystalline Bortezomib, which is crucial for the treatment of certain cancers. This invention focuses on creating highly pure crystalline Bortezomib and its pharmaceutical acceptable salts. Another significant patent involves the process for the preparation of Fingolimod hydrochloride, which is an active pharmaceutical ingredient used in treating autoimmune disorders, including multiple sclerosis. These innovations highlight his commitment to advancing medical treatments through innovative processes.
Career Highlights
Throughout his career, Rafiuddin has worked with prominent companies such as Shilpa Medicare Limited and Shilpa Pharma Lifesciences Limited. His experience in these organizations has allowed him to refine his skills and contribute to the development of essential pharmaceutical products.
Collaborations
Rafiuddin has collaborated with talented professionals in the industry, including Vinod Kumar Singh and Vimal Kumar Shrawat. These partnerships have further enhanced his ability to innovate and create impactful pharmaceutical solutions.
Conclusion
Rafiuddin Dr's contributions to the pharmaceutical industry through his patents and collaborations demonstrate his dedication to improving healthcare. His work continues to influence the development of vital medications that address significant health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile